Ardena is a pharmaceutical CDMO that guides companies through the drug discovery and development process to help create effective and compliant drug substance and products for clinical trials.
Ardena provides you with an integrated service offering including solid state chemistry, API & nanomedicines development and manufacturing, analytical & formulation development, drug product manufacturing, bioanalytical, drug discovery and dossier development services.
Headquartered in Ghent, we have facilities in the Netherlands, Belgium, Sweden and Spain, serving a global customer base, ranging from emerging biotech to tier-one pharmaceutical companies.
We understand the complex challenges involved in taking a promising molecule from lab to patient.
Each project we undertake is preceded by a detailed planning phase to ensure that the right work is carried out at the right time. This staged approach allows you to stagger your investments and mitigate risks during each phase of the project.
Our integrated offering is the engine that drives all of our projects. Our multidisciplinary team is keen to streamline your development process.
We also make sure that all the work we do for you is compliant with the appropriate regulatory standards as you move along the clinical development path. Our dossier-centric approach is key to help you compile your regulatory dossier in a timely and cost-efficient manner. By preparing your regulatory dossier in parallel with drug development, we ultimately get your drug to patients faster.
-
Industry
-
Pharmaceutical Manufacturing
-
Company size
-
501-1,000 employees
-
Headquarters
-
Mariakerke, East Flanders
-
Type
-
Privately Held
-
Founded
-
2017
-
Specialties
-
Solid state research, Nanomedicines, API, Formulation development, GMP Manufacturing, Bioanalytics, Regulatory & scientific writing, Contract Development & Manufacturing Organization, CDMO, Drug Product, Drug Substance, Clinical logistics, Pharma, and Pharmaceutical company
